Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...
Positive Phase 1 data for CTX310® presented in a late-breaking presentation at the American Heart Association (AHA) ...
New preclinical data for PM577 in Wilson’s Disease (WD) to be presented at AASLD; on-track to file IND and/or CTA in H1’26, with initial ...
New preclinical data for PM577 in Wilson's Disease (WD) to be presented at AASLD; on-track to file IND and/or CTA in H1'26, with initial clinical data expected in 2027 -- -- Nominated PM647 as develop ...
Iron deficiency anaemia is a widespread issue affecting children globally. This condition impacts physical health, brain ...
The First And Only Treatment For Adults And Children Living With Thymidine Kinase 2 Deficiency (Tk2d). <li /> Approved indication: KYGEVVITM (doxecitine and doxribtimine) powder for oral solution (2 ...
Lexeo Therapeutics, Inc. surges after FDA trial alignment for LX2006 in Friedreich’s ataxia. Click for more on LXEO stock ...
ANTHONY Hopkins revealed the shocking moment he realised he was addicted to alcohol – and it could kill him. “I never had any ...
Detailed price information for Phathom Pharmaceuticals Inc (PHAT-Q) from The Globe and Mail including charting and trades.
Oxford University and Austrian researchers uncover a previously unknown ‘handbrake’ mechanism controlling how cells respond to cancer drugs, reshaping global understanding of cell metabolism and drug ...
4d
Medical Professionals Are Sharing 20 Patients Who Turned Out To Be Correct About Wild Self-Diagnoses
"He reported worsening mobility over the past six months. He had not had medical care in many years. I saw him, and to me, ...
Oxford University and Austrian researchers uncover a previously unknown 'handbrake' mechanism controlling how cells respond to cancer drugs, reshaping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback